| Tissue-engineered bone repair of sheep cranial defects with autologous bone marrow stromal cells Q Shang, Z Wang, W Liu, Y Shi, L Cui, Y Cao Journal of Craniofacial Surgery 12 (6), 586-593, 2001 | 383 | 2001 |
| New and emerging targeted therapies for advanced breast cancer KH Lau, AM Tan, Y Shi International journal of molecular sciences 23 (4), 2288, 2022 | 122 | 2022 |
| Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma S Batra, Y Shi, KM Kuchenbecker, B He, N Reguart, I Mikami, L You, Z Xu, ... Biochemical and biophysical research communications 342 (4), 1228-1232, 2006 | 120 | 2006 |
| Metallothionein induction by hypoxia involves cooperative interactions between metal-responsive transcription factor-1 and hypoxia-inducible transcription factor-1α BJ Murphy, T Kimura, BG Sato, Y Shi, GK Andrews Molecular Cancer Research 6 (3), 483-490, 2008 | 103 | 2008 |
| Impact of bile acids on the growth of human cholangiocarcinoma via FXR J Dai, H Wang, Y Shi, Y Dong, Y Zhang, J Wang Journal of hematology & oncology 4, 1-8, 2011 | 96 | 2011 |
| Roles of secreted frizzled‐related proteins in cancer1 Y Shi, B He, L You, DM Jablons Acta Pharmacologica Sinica 28 (9), 1499-1504, 2007 | 83 | 2007 |
| Inhibition of Wnt‐2 and galectin‐3 synergistically destabilizes β‐catenin and induces apoptosis in human colorectal cancer cells Y Shi, B He, KM Kuchenbecker, L You, Z Xu, I Mikami, A Yagui‐Beltran, ... International journal of cancer 121 (6), 1175-1181, 2007 | 78 | 2007 |
| Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth YC Lin, L You, Z Xu, B He, CT Yang, JK Chen, I Mikami, G Clément, Y Shi, ... Human gene therapy 18 (4), 379-386, 2007 | 76 | 2007 |
| Inositol phosphates and phosphoinositides in health and disease Y Shi, AN Azab, MN Thompson, ML Greenberg Biology of Inositols and Phosphoinositides: Subcellular Biochemistry, 265-292, 2006 | 67 | 2006 |
| Epigenetic alteration of the Wnt inhibitory factor‐1 promoter occurs early in the carcinogenesis of Barrett's esophagus G Clément, I Guilleret, B He, A Yagui‐Beltrán, YC Lin, L You, Z Xu, Y Shi, ... Cancer science 99 (1), 46-53, 2008 | 64 | 2008 |
| EMX2 is epigenetically silenced and suppresses growth in human lung cancer J Okamoto, T Hirata, Z Chen, HM Zhou, I Mikami, H Li, A Beltran, ... Oncogene 29 (44), 5969-5975, 2010 | 59 | 2010 |
| Genetic perturbation of glycolysis results in inhibition of de novo inositol biosynthesis Y Shi, DL Vaden, S Ju, D Ding, JH Geiger, ML Greenberg Journal of Biological Chemistry 280 (51), 41805-41810, 2005 | 51 | 2005 |
| A novel tumor-activated prodrug strategy targeting ferrous iron is effective in multiple preclinical cancer models B Spangler, SD Fontaine, Y Shi, L Sambucetti, AN Mattis, B Hann, ... Journal of medicinal chemistry 59 (24), 11161-11170, 2016 | 43 | 2016 |
| The metal-responsive transcription factor-1 protein is elevated in human tumors Y Shi, K Amin, BG Sato, SJ Samuelsson, L Sambucetti, ZA Haroon, ... Cancer biology & therapy 9 (6), 469-476, 2010 | 39 | 2010 |
| Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges S Toulouie, G Johanning, Y Shi Journal of Cancer 12 (4), 1212, 2021 | 31 | 2021 |
| Perturbation of the vacuolar ATPase: a novel consequence of inositol depletion RM Deranieh, Y Shi, M Tarsio, Y Chen, JM McCaffery, PM Kane, ... Journal of Biological Chemistry 290 (46), 27460-27472, 2015 | 26 | 2015 |
| Breast cancer predisposition genes and synthetic lethality HE Neiger, EL Siegler, Y Shi International journal of molecular sciences 22 (11), 5614, 2021 | 24 | 2021 |
| An effective up-sampling approach for breast cancer prediction with imbalanced data: A machine learning model-based comparative analysis T Tran, U Le, Y Shi Plos one 17 (5), e0269135, 2022 | 22 | 2022 |
| An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applications Y Shi, W Bray, AJ Smith, W Zhou, J Calaoagan, C Lagisetti, L Sambucetti, ... PloS one 15 (5), e0233672, 2020 | 22 | 2020 |
| A triple exon-skipping luciferase reporter assay identifies a new CLK inhibitor pharmacophore (vol 27, pg 406, 2017) Y Shi, J Park, C Lagisetti, W Zhou, LC Sambucetti, TR Webb BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 27 (6), 1488-1489, 2017 | 21* | 2017 |
